Paradigm Biopharmaceuticals Ltd.ASX: PAR

Paradigms preclinical hay fever trial published

May 16, 2017 at 2:50 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment